A research by doctors from Ozone Forum of India has found ozone therapy successful in 77 per cent of mild to moderate cases of Covid-19 in the first five days.
“The use of ozone therapy in mild to moderate cases has shown 77 per cent success rate in the first five days,” Dr Mili Shah, vice-president, Ozone Forum of India, said at a press conference.
Ozone Forum of India is an initiative of Bisleri Charitable Trust. The trials were conducted by Ozone Forum and Lokmanya Medical Research Centre, Chinchwad.
Counting the benefits of ozone therapy, Dr Shah said, “It improves circulation, metabolism and ensures generalised well-being… Ozone has potent anti-inflammatory, germicidal and anti-oxidant effect on
the body. It can reduce harmful effects of over-stimulation of the immune system and prevent progression of mild to moderate stage patients to severe stage…”
Dr Jignasha Captain, director, Ozone Forum of India, said, “On day 5 of ozone treatment, 77 per cent subjects treated negative in RT-PCR tests with significant reduction in cough and breathlessness…”
Dr Gayatri Ganu, director, clinic research for Lokmanya Hospital, said, “After CTRI and ICMR approval, we provided ozone therapy along with standard care to 60 mild to moderate Covid-19 patients.”